Purchasing evidence: the corollary of evidence-based purchasing

Summary The National Health Service (NHS) market led to problems in funding research and development (R&D). The current policy is to resolve these by funding R&D through a national levy on purchasers. The policy does not, however, address the underlying problem that evidence produced by R&am...

Full description

Saved in:
Bibliographic Details
Published in:Journal of public health (Oxford, England) England), 1997-03, Vol.19 (1), p.6-10
Main Authors: Gray, Selena F., Bevan, Gwyn, Frankel, Stephen
Format: Article
Language:English
Subjects:
Community Participation
Evidence based purchasing
Evidence-Based Medicine
Health Policy
Humans
Mass Screening - economics
National health services
Public Health
purchasing
Research and development
Research Support as Topic
State Medicine
Technology Assessment, Biomedical - economics
United Kingdom
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Summary The National Health Service (NHS) market led to problems in funding research and development (R&D). The current policy is to resolve these by funding R&D through a national levy on purchasers. The policy does not, however, address the underlying problem that evidence produced by R&D is largely irrelevant to purchasers. The consequences of this policy are likely to be that purchasing will have limited impact in securing health gain most effectively, the progress and impact of R&D will be impaired, and its funding will remain insecure. If R&D and purchasing were integrated each could become more effective. This integration can be fostered through developing the regulation of purchasers and providers within the NHS market.
ISSN:1741-3842
0957-4832
1741-3850
1464-3782
DOI:10.1093/oxfordjournals.pubmed.a024589